{"transactions":[{"id":1091816,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-03T11:06:18.000Z","date":"2025-07-01","kind":"grant","planned":false,"acquired":true,"shares":25461,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Johnson pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on July 1, 2026, and 33% on July 1, 2027, and July 1, 2028."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a portion of the award approved by the Compensation Committee of the Company's Board of Directors as part of the annual award cycle.  The first portion of the award was granted on March 3, 2025, and this portion of the award was contingent upon the approval of the issuance of additional shares under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.  The Company's shareholders approved the issuance of additional shares under the Amended and Restated 2015 Omnibus Incentive Compensation Plan on June 5, 2025, at the Company's Annual Meeting."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":309245,"source":{"system":"sec-edgar","filing":"0001628908-25-000100","document":"wk-form4_1751540772.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000100/wk-form4_1751540772.xml","form_type":"4"}},{"id":1226260,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:09:33.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":26872,"price":8.77,"value":235667.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":283784,"source":{"system":"sec-edgar","filing":"0001628908-25-000022","document":"wk-form4_1741129767.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000022/wk-form4_1741129767.xml","form_type":"4"}},{"id":1226259,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:09:33.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":59582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of\nachievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of\nthe performance period on December 31, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":310656,"source":{"system":"sec-edgar","filing":"0001628908-25-000022","document":"wk-form4_1741129767.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000022/wk-form4_1741129767.xml","form_type":"4"}},{"id":1226258,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:09:33.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":89113,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F4","text":"Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":251074,"source":{"system":"sec-edgar","filing":"0001628908-25-000022","document":"wk-form4_1741129767.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000022/wk-form4_1741129767.xml","form_type":"4"}},{"id":1226257,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-03-04T23:09:33.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":9246,"price":8.99,"value":83121.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":161961,"source":{"system":"sec-edgar","filing":"0001628908-25-000022","document":"wk-form4_1741129767.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890825000022/wk-form4_1741129767.xml","form_type":"4"}},{"id":1422965,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-08-27T00:11:05.000Z","date":"2024-08-22","kind":"sale","planned":true,"acquired":false,"shares":44693,"price":30,"value":1340790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.01, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":171207,"source":{"system":"sec-edgar","filing":"0001628908-24-000094","document":"wk-form4_1724717458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000094/wk-form4_1724717458.xml","form_type":"4"}},{"id":1594038,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-06T00:09:42.000Z","date":"2024-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9020,"price":34.41,"value":310378.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":215900,"source":{"system":"sec-edgar","filing":"0001628908-24-000034","document":"wk-form4_1709683768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000034/wk-form4_1709683768.xml","form_type":"4"}},{"id":1594037,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-06T00:09:42.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":11213,"price":34.41,"value":385839.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":224920,"source":{"system":"sec-edgar","filing":"0001628908-24-000034","document":"wk-form4_1709683768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000034/wk-form4_1709683768.xml","form_type":"4"}},{"id":1594036,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-03-06T00:09:42.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":12123,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2025, and 33% on March 1, 2026, and March 1, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":236133,"source":{"system":"sec-edgar","filing":"0001628908-24-000034","document":"wk-form4_1709683768.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000034/wk-form4_1709683768.xml","form_type":"4"}},{"id":1618590,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-26T21:43:10.000Z","date":"2024-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":20006,"price":33.03,"value":660798.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of performance stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":224010,"source":{"system":"sec-edgar","filing":"0001628908-24-000021","document":"wk-form4_1708983759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000021/wk-form4_1708983759.xml","form_type":"4"}},{"id":1618589,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-26T21:43:10.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares received upon the settlement of the second tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the second tranche of the PSU award vested at the conclusion of the performance period on December 31, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":244016,"source":{"system":"sec-edgar","filing":"0001628908-24-000021","document":"wk-form4_1708983759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890824000021/wk-form4_1708983759.xml","form_type":"4"}},{"id":1971517,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:37:47.000Z","date":"2023-03-02","kind":"tax_withholding","acquired":false,"shares":9020,"price":35.15,"value":317053.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":200016,"source":{"system":"sec-edgar","filing":"0001628908-23-000039","document":"wf-form4_167788304937171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000039/wf-form4_167788304937171.xml","form_type":"4"}},{"id":1971516,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:37:47.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":3681,"price":35.26,"value":129792.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":209036,"source":{"system":"sec-edgar","filing":"0001628908-23-000039","document":"wf-form4_167788304937171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000039/wf-form4_167788304937171.xml","form_type":"4"}},{"id":1971515,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-03T22:37:47.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":20413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2024, and 33% on March 1, 2025, and March 1, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":212717,"source":{"system":"sec-edgar","filing":"0001628908-23-000039","document":"wf-form4_167788304937171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000039/wf-form4_167788304937171.xml","form_type":"4"}},{"id":1995268,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T00:16:56.000Z","date":"2023-02-21","kind":"tax_withholding","acquired":false,"shares":20025,"price":28.08,"value":562302.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of PSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":192304,"source":{"system":"sec-edgar","filing":"0001628908-23-000023","document":"wf-form4_167719779801664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000023/wf-form4_167719779801664.xml","form_type":"4"}},{"id":1995267,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-24T00:16:56.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares received upon the settlement of the first tranche of performance-based share units (PSUs) awarded to the reporting person on March 1, 2021, following the certification of achievement of specified performance metrics. The shares underlying the first tranche of the PSU award vested at the conclusion of the performance period on December 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":212329,"source":{"system":"sec-edgar","filing":"0001628908-23-000023","document":"wf-form4_167719779801664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890823000023/wf-form4_167719779801664.xml","form_type":"4"}},{"id":2179082,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-08-18T22:04:57.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":18434,"price":34.11,"value":628783.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.11 to $34.22, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":168329,"source":{"system":"sec-edgar","filing":"0001628908-22-000118","document":"wf-form4_166086027820113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000118/wf-form4_166086027820113.xml","form_type":"4"}},{"id":2349556,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Leveraged Restricted Stock Unit","published_at":"2022-03-05T01:59:04.000Z","date":"2022-03-02","kind":"exercise","acquired":false,"shares":71716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Leveraged Stock Units vested on March 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The Leveraged Stock Units do not expire."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Class A Common Stock","underlying_shares":71716},"source":{"system":"sec-edgar","filing":"0001628908-22-000043","document":"wf-form4_164644552440218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000043/wf-form4_164644552440218.xml","form_type":"4"}},{"id":2349555,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-05T01:59:04.000Z","date":"2022-03-03","kind":"tax_withholding","acquired":false,"shares":32344,"price":27.54,"value":890753.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of leveraged stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":186763,"source":{"system":"sec-edgar","filing":"0001628908-22-000043","document":"wf-form4_164644552440218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000043/wf-form4_164644552440218.xml","form_type":"4"}},{"id":2349554,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-05T01:59:04.000Z","date":"2022-03-02","kind":"tax_withholding","acquired":false,"shares":9020,"price":27.54,"value":248410.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":219107,"source":{"system":"sec-edgar","filing":"0001628908-22-000043","document":"wf-form4_164644552440218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000043/wf-form4_164644552440218.xml","form_type":"4"}},{"id":2349553,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-05T01:59:04.000Z","date":"2022-03-02","kind":"exercise","acquired":true,"shares":71716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the vesting of the leveraged stock units granted to Mr. Johnson on March 1, 2019, based on the cumulative performance of the Issuer's Class A Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":228127,"source":{"system":"sec-edgar","filing":"0001628908-22-000043","document":"wf-form4_164644552440218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000043/wf-form4_164644552440218.xml","form_type":"4"}},{"id":2352645,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:34:45.000Z","date":"2022-03-01","kind":"tax_withholding","acquired":false,"shares":4510,"price":27.4,"value":123574.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":156411,"source":{"system":"sec-edgar","filing":"0001628908-22-000039","document":"wf-form4_164636126999318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000039/wf-form4_164636126999318.xml","form_type":"4"}},{"id":2352644,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2022-03-04T02:34:45.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 34% on March 1, 2023, and 33 % on March 1, 2024, and March 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":160921,"source":{"system":"sec-edgar","filing":"0001628908-22-000039","document":"wf-form4_164636126999318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890822000039/wf-form4_164636126999318.xml","form_type":"4"}},{"id":2811231,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2021-03-04T01:46:35.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Includes restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning March 1, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission."}],"balance_after":136921,"source":{"system":"sec-edgar","filing":"0001628908-21-000032","document":"wf-form4_161482238021079.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890821000032/wf-form4_161482238021079.xml","form_type":"4"}},{"id":3226318,"issuer":{"id":5492,"kind":"organization","name":"Evolent Health, Inc."},"owners":[{"id":77684,"kind":"person","name":"Johnson John Paul","position":1,"cik":"0001782040","reported_name":"Johnson John Paul","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2020-03-04T21:50:08.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. Omnibus Incentive Compensation Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"Securities vest at a rate of 25% annually beginning March 2,2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted stock units reported on Table 1 of Form 3 previously filed with the Securities and Exchange Commission."}],"balance_after":96921,"source":{"system":"sec-edgar","filing":"0001628908-20-000034","document":"wf-form4_158335859172066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890820000034/wf-form4_158335859172066.xml","form_type":"4"}}]}